Published in Exp Hematol on July 01, 1993
Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors. J Virol (1994) 1.63
Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector. J Clin Invest (1994) 1.39
Recombinant adeno-associated virus (rAAV)-mediated expression of a human gamma-globin gene in human progenitor-derived erythroid cells. Proc Natl Acad Sci U S A (1994) 1.28
Adeno-associated virus 2-mediated high efficiency gene transfer into immature and mature subsets of hematopoietic progenitor cells in human umbilical cord blood. J Exp Med (1994) 1.26
Recombinant adeno-associated virus mediates a high level of gene transfer but less efficient integration in the K562 human hematopoietic cell line. J Virol (1997) 1.12
Enhanced long-term transduction and multilineage engraftment of human hematopoietic stem cells transduced with tyrosine-modified recombinant adeno-associated virus serotype 2. Hum Gene Ther (2010) 1.05
Adeno-associated virus vectors and hematology. Blood (1999) 1.03
Parvovirus B19 promoter at map unit 6 confers autonomous replication competence and erythroid specificity to adeno-associated virus 2 in primary human hematopoietic progenitor cells. Proc Natl Acad Sci U S A (1995) 0.99
Suppression of human alpha-globin gene expression mediated by the recombinant adeno-associated virus 2-based antisense vectors. J Exp Med (1994) 0.94
Recombinant AAV2 transduction of primitive human hematopoietic stem cells capable of serial engraftment in immune-deficient mice. Proc Natl Acad Sci U S A (2005) 0.88
Transduction of folate receptor cDNA into cervical carcinoma cells using recombinant adeno-associated virions delays cell proliferation in vitro and in vivo. J Clin Invest (1995) 0.86
Transcriptional transactivation of parvovirus B19 promoters in nonpermissive human cells by adenovirus type 2. J Virol (1995) 0.85
Development of Novel Recombinant AAV Vectors and Strategies for the Potential Gene Therapy of Hemophilia. J Genet Syndr Gene Ther (2012) 0.82
Adeno-associated virus (AAV) vectors: will they work? J Clin Invest (1994) 0.80
Protective CD8+ T-cell responses to cytomegalovirus driven by rAAV/GFP/IE1 loading of dendritic cells. J Transl Med (2008) 0.75
The frequency of discharge from the spinal cord in the frog. J Physiol (1923) 21.70
Chromosome replication and the division cycle of Escherichia coli B/r. J Mol Biol (1968) 21.06
The isometric responses of mammalian muscles. J Physiol (1930) 19.26
On the thymus in the differentiation of "H-2 self-recognition" by T cells: evidence for dual recognition? J Exp Med (1978) 9.51
Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest (1997) 7.58
Nucleotide sequence and organization of the adeno-associated virus 2 genome. J Virol (1983) 7.52
Imported malaria: prospective analysis of problems in diagnosis and management. Clin Infect Dis (1998) 7.29
On the bacterial life sequence. Cold Spring Harb Symp Quant Biol (1968) 6.99
A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity (1996) 5.64
Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat Med (1999) 5.50
Reflex effects of active muscular contraction. J Physiol (1927) 5.46
Rescue of adeno-associated virus from recombinant plasmids: gene correction within the terminal repeats of AAV. Cell (1983) 5.27
More reflex effects of active muscular contraction. J Physiol (1927) 5.07
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost (2006) 4.58
The lymphoreticular system in triggering virus plus self-specific cytotoxic T cells: evidence for T help. J Exp Med (1978) 4.27
Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci U S A (1989) 4.13
Detection of sickle cell anaemia and thalassaemias. Nature (1987) 3.94
Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. J Virol Methods (1991) 3.78
Delta-F508 cystic fibrosis mutation is not linked to intussusception: implications for rotavirus vaccine. J Paediatr Child Health (2003) 3.59
Parasight F test compared with the polymerase chain reaction and microscopy for the diagnosis of Plasmodium falciparum malaria in travelers. Am J Trop Med Hyg (1997) 3.56
Hyperacute thrombolysis with IV rtPA of acute ischemic stroke: efficacy and safety profile of 54 patients at a tertiary referral center in a developing country. Neurol India (2007) 3.52
Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood (1980) 3.51
Does induction of labour increase the risk of caesarean section? A systematic review and meta-analysis of trials in women with intact membranes. BJOG (2013) 3.37
Expression of Ia-like antigen molecules on human granulocytes during early phases of differentiation. Proc Natl Acad Sci U S A (1977) 2.80
Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J Exp Med (1997) 2.79
A temperature sensitive nonsense mutation affecting the synthesis of a major protein of Escherichia coli K12. Mol Gen Genet (1975) 2.79
Transplantation of umbilical cord blood after myeloablative therapy: analysis of engraftment. Blood (1992) 2.77
Birth of a biome: insights into the assembly and maintenance of the Australian arid zone biota. Mol Ecol (2008) 2.73
Identification of nuclear proteins that specifically interact with adeno-associated virus type 2 inverted terminal repeat hairpin DNA. J Virol (1989) 2.60
Comparison of the ParaSight-F test and the ICT Malaria Pf test with the polymerase chain reaction for the diagnosis of Plasmodium falciparum malaria in travellers. Trans R Soc Trop Med Hyg (1998) 2.56
The relation of active to inactive fibres in fractional contraction of muscle. J Physiol (1929) 2.45
The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study. J Thromb Haemost (2005) 2.45
The rate of recovery of nerves in asphyxia. J Physiol (1923) 2.43
Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc Natl Acad Sci U S A (1992) 2.41
Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet (1995) 2.40
Chemokines: signal lamps for trafficking of T and B cells for development and effector function. J Leukoc Biol (1999) 2.34
Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production. J Immunol (2001) 2.28
Ir-genes in H-2 regulate generation of anti-viral cytotoxic T cells. Mapping to K or D and dominance of unresponsiveness. J Exp Med (1978) 2.24
Convergent sensing pathways mediate response to two extracellular competence factors in Bacillus subtilis. Genes Dev (1995) 2.24
Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer. Ann Intern Med (1997) 2.22
Evaluation of neuroleptic drug use by nursing home elderly under proposed Medicare and Medicaid regulations. JAMA (1991) 2.18
Randomized controlled trial of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: the POPMACT study. Psychol Med (2003) 2.16
Neovascularization in human cutaneous melanoma: a quantitative morphological and Doppler ultrasound study. Eur J Cancer Clin Oncol (1986) 2.12
Trial of two bandaging systems for chronic venous leg ulcers. J Wound Care (1997) 2.09
Disseminated infection with Mycobacterium kansasii in the acquired immunodeficiency syndrome. Ann Intern Med (1986) 2.09
Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively. Am J Hum Genet (2001) 2.08
Methylation and expression of the Myo D1 determination gene. Philos Trans R Soc Lond B Biol Sci (1990) 2.06
X chromosome map at 75-kb STS resolution, revealing extremes of recombination and GC content. Genome Res (1997) 2.06
A note on the retinal action potential of the human eye. J Physiol (1933) 2.05
Adeno-associated virus type 2-mediated gene transfer: altered endocytic processing enhances transduction efficiency in murine fibroblasts. J Virol (2001) 2.03
Impaired intracellular trafficking of adeno-associated virus type 2 vectors limits efficient transduction of murine fibroblasts. J Virol (2000) 2.01
Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain (2004) 1.96
Rejection of skin allografts by radiation chimaeras: selective gene action in the specification of cell surface structure. Nature (1970) 1.95
Identification of lactoferrin as the granulocyte-derived inhibitor of colony-stimulating activity production. J Exp Med (1978) 1.94
Multiple inhibitory cytokines induce deregulated progenitor growth and apoptosis in hematopoietic cells from Fac-/- mice. Blood (1998) 1.93
Should ice be used in the treatment of acute haemarthrosis in haemophilia? Haemophilia (2013) 1.92
Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression. Proc Natl Acad Sci U S A (1997) 1.91
Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells. J Immunol (1983) 1.88
Isolation and characterization of Exodus-2, a novel C-C chemokine with a unique 37-amino acid carboxyl-terminal extension. J Immunol (1997) 1.87
Acute hepatitis C. Hepatology (2001) 1.82
MHC I-dependent antigen presentation is inhibited by poliovirus protein 3A. Proc Natl Acad Sci U S A (2000) 1.78
Treatment of multiple sclerosis with T-cell receptor peptides: results of a double-blind pilot trial. Nat Med (1996) 1.78
Treatment of children with newly diagnosed acute promyelocytic leukemia with arsenic trioxide: a single center experience. Leukemia (2004) 1.76
Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br J Cancer (2001) 1.73
Comparison of bronchial reactivity and peak expiratory flow variability measurements for epidemiologic studies. Am Rev Respir Dis (1992) 1.73
Cytokines in human milk. Res Commun Mol Pathol Pharmacol (1996) 1.70
Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter study. J Thromb Haemost (2006) 1.70
Membrane-bound Steel factor induces more persistent tyrosine kinase activation and longer life span of c-kit gene-encoded protein than its soluble form. Blood (1995) 1.69
Cell division and DNA replication following a shift to a richer medium. J Mol Biol (1969) 1.68
The effect of carbon dioxide on the rate of recovery in nerve. J Physiol (1924) 1.67
Dengue virus infection in renal allograft recipients: a case series during 2010 outbreak. Transpl Infect Dis (2011) 1.67
Plasma concentrations of local anaesthetics after interscalene brachial plexus block. Br J Anaesth (1977) 1.66
Low levels of erythroid and myeloid progenitors in thrombopoietin-and c-mpl-deficient mice. Blood (1996) 1.63
Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost (2000) 1.62
Phosphorylation of nuclear MyoD is required for its rapid degradation. Mol Cell Biol (1998) 1.61
Limitation of excessive myelopoiesis by the intrinsic modulation of macrophage-derived prostaglandin E. Science (1978) 1.60
Adeno-associated virus 2-mediated gene transfer in vivo: organ-tropism and expression of transduced sequences in mice. Gene (1997) 1.60
CK beta-11/macrophage inflammatory protein-3 beta/EBI1-ligand chemokine is an efficacious chemoattractant for T and B cells. J Immunol (1998) 1.60
Enhancing and suppressing effects of recombinant murine macrophage inflammatory proteins on colony formation in vitro by bone marrow myeloid progenitor cells. Blood (1990) 1.58
Adeno-associated virus type 2-mediated gene transfer: role of cellular FKBP52 protein in transgene expression. J Virol (2001) 1.58
In irradiation chimeras, K or D regions of the chimeric host, not of the donor lymphocytes, determine immune responsiveness of antiviral cytotoxic T cells. J Exp Med (1978) 1.57
Radiological intervention in Budd-Chiari syndrome: techniques and outcome in 18 patients. Clin Radiol (1996) 1.57
Cloning of BRAK, a novel divergent CXC chemokine preferentially expressed in normal versus malignant cells. Biochem Biophys Res Commun (1999) 1.56
Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes. N Engl J Med (1987) 1.55
SCID mice as an in vivo model of human cord blood hematopoiesis. Blood Cells (1994) 1.54
Pulmonary edema associated with troglitazone therapy. Arch Intern Med (1999) 1.52
Regulation of macrophage and granulocyte proliferation. Specificities of prostaglandin E and lactoferrin. J Exp Med (1979) 1.51
A pilot study on the role of T-tube in typhoid ileal perforation in children. World J Surg (2008) 1.51